FDA warning letters: GLP-1 (semaglutide, tirzepatide)
This page lists public FDA records related to GLP-1 (semaglutide, tirzepatide). Inclusion does not mean a company is currently out of compliance. Topics are assigned by keyword matching on FDA's subject line.
No GLP-1 letters in the current window yet. Get the weekly digest and see new ones as they're posted.
Get new FDA warning letters by email. One digest a week, free.
Double opt-in: we email you a link to confirm. One-click unsubscribe in every email. You must be at least 18. See our Privacy policy.
Most recent letters
- Eurofins SF Analytical Laboratories, Inc.
Oct 6, 2026 · CGMP/Finished Pharmaceuticals/Adulterated - originalc.co.uk
Oct 2, 2026 · Family Smoking Prevention and Tobacco Control Act/Adulterated/Misbranded - Hanlim Pharm Co., Ltd.
Oct 2, 2026 · CGMP/Finished Pharmaceuticals/Adulterated